---
figid: PMC3804348__cns-02-289-g1
figlink: /pmc/articles/PMC3804348/figure/F0001/
number: F1
caption: 'Receptor tyrosine kinase/PI3K/Akt signaling via upregulation of SREBP-1
  promotes fatty acid synthesis and cholesterol uptake. ACC and FAS are direct downstream
  genes of SREBP-1 and key molecules in the regulation of de novo fatty acid synthesis.
  LDLR is upregulated by SREBP-1 to promote cholesterol uptake. Activation of LXR
  stimulates ABCA1 expression and promotes cholesterol efflux; it also reduces LDLR
  levels via upregulating Idol, a ubiquitin ligase E3. The light red boxes designate
  the molecules upregulated in glioblastoma (GBM) and could be potential therapeutic
  targets in GBM. The light blue boxes signify the molecules that negatively regulate
  GBM growth. Fatostatin is a SREBP-1 inhibitor; GW3965 is a LXR synthetic agonist;
  HMG-CoA R is a key enzyme in the pathway of de novo cholesterol synthesis; and statin
  is a HMG-CoA R inhibitor.HMG-CoA R: HMG-CoA reductase; LDLR: Low-density lipoprotein
  receptor; RTK: Receptor tyrosine kinase.'
pmcid: PMC3804348
papertitle: Lipid metabolism emerges as a promising target for malignant glioma therapy.
reftext: Deliang Guo, et al. CNS Oncol. 2013 May;2(3):289-299.
pmc_ranked_result_index: '14127'
pathway_score: 0.961296
filename: cns-02-289-g1.jpg
figtitle: Regulation of lipid metabolism in glioblastoma and the therapeutic drug
  targets
year: '2013'
organisms: Homo sapiens
ndex: c09838c1-dec0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3804348__cns-02-289-g1.html
  '@type': Dataset
  description: 'Receptor tyrosine kinase/PI3K/Akt signaling via upregulation of SREBP-1
    promotes fatty acid synthesis and cholesterol uptake. ACC and FAS are direct downstream
    genes of SREBP-1 and key molecules in the regulation of de novo fatty acid synthesis.
    LDLR is upregulated by SREBP-1 to promote cholesterol uptake. Activation of LXR
    stimulates ABCA1 expression and promotes cholesterol efflux; it also reduces LDLR
    levels via upregulating Idol, a ubiquitin ligase E3. The light red boxes designate
    the molecules upregulated in glioblastoma (GBM) and could be potential therapeutic
    targets in GBM. The light blue boxes signify the molecules that negatively regulate
    GBM growth. Fatostatin is a SREBP-1 inhibitor; GW3965 is a LXR synthetic agonist;
    HMG-CoA R is a key enzyme in the pathway of de novo cholesterol synthesis; and
    statin is a HMG-CoA R inhibitor.HMG-CoA R: HMG-CoA reductase; LDLR: Low-density
    lipoprotein receptor; RTK: Receptor tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FAS
  - ACACA
  - SREBF1
  - PIK3R4
  - PIK3CB
  - AKT2
  - ABCA1
  - PIK3CA
  - LDLR
  - ACACB
  - PIK3R3
  - PIK3R6
  - MYLIP
  - AKT1
  - PIK3CG
  - SREBF2
  - PIK3CD
  - AKT3
  - PIK3R5
  - MTOR
  - Fatostatin
  - Cholesterol
  - Fatty acids
genes:
- word: ACC/FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: ACC/FAS
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: SREBP-1
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ABCA1
  symbol: ABCA1
  source: hgnc_symbol
  hgnc_symbol: ABCA1
  entrez: '19'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: ACC/FAS
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Idol
  symbol: IDOL
  source: hgnc_alias_symbol
  hgnc_symbol: MYLIP
  entrez: '29116'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: SREBP-2
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RTK/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: Fatostatin
  source: MESH
  identifier: C545733
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Fatty acids
  source: MESH
  identifier: D005227
diseases: []
figid_alias: PMC3804348__F1
redirect_from: /figures/PMC3804348__F1
figtype: Figure
---
